AI Article Synopsis

  • Autoantibodies targeting the GluR3 subtype of AMPA receptors are found in some epilepsy patients, suggesting they might influence the disease's development.
  • Researchers examined antibodies against a specific GluR3 peptide (GluR3B) and found that these antibodies can directly activate GluR3 receptors in a lab setting without needing other biological factors.
  • The study explores the characteristics of these antibodies and considers their potential effects on glutamate receptor activity, which could have important implications for understanding epilepsy.

Article Abstract

Autoantibodies to the GluR3-subtype of AMPA/glutamate receptors are found in the sera and cerebrospinal fluid of some individuals with epilepsy. They could possibly play a role in the pathophysiology of epilepsy since anti-GluR3 sera display glutamatergic agonist activity. We have investigated here the ability of affinity-purified antibodies (Abs) directed against the immunogenic peptide GluR3B (amino-acid 372-395) to interact with and activate recombinant GluR3-receptor channels expressed by Xenopus oocytes. We report here that the affinity-purified anti-GluR3B Abs directly activate GluR3-containing homomeric and heteromeric AMPA receptor complexes without the requirement of neuronal, glial or blood ancillary molecules. We present some of the properties of the purified anti-GluR3B Abs and discuss the possible physiological or pathological consequences of their activation of glutamate receptors.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11064-006-9143-6DOI Listing

Publication Analysis

Top Keywords

homomeric heteromeric
8
heteromeric ampa
8
ampa receptor
8
anti-glur3b abs
8
autoantibodies extracellular
4
extracellular peptide
4
peptide glur3
4
glur3 subtype
4
subtype ampa
4
ampa receptors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!